SHARON JACOBSON: Open Payments
NPI 1376631473 · ENGLEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$235 in 23 payments from 8 companies in 2025. Trend: 2023 $114 · 2024 $153 · 2025 $235
Food & beverage: $235
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 15 | $108 |
| Organon LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 2 | $18 |
| Octapharma USA, Inc. | 1 | $14 |
Products named: JADA SYSTEM, Mirena, Veozah, GARDASIL 9, MYFEMBREE, Phexxi, FIBRYGA.
Industry payments across NJ — which companies pay providers there.
